-
1
-
-
0022614124
-
Pathogenesis of diabetic microangiopathy: The hemodynamic view
-
Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy: the hemodynamic view. Am J Med 1986;80:443-453.
-
(1986)
Am J Med
, vol.80
, pp. 443-453
-
-
Zatz, R.1
Brenner, B.M.2
-
2
-
-
0027746169
-
Systemic hypertension and the renin-angiotensin system indiabetic vascular complications
-
Hsueh WA, Anderson PW. Systemic hypertension and the renin-angiotensin system indiabetic vascular complications. Am J Cardiol 1993;72:14H-21H.
-
(1993)
Am J Cardiol
, vol.72
-
-
Hsueh, W.A.1
Anderson, P.W.2
-
3
-
-
0028121082
-
Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications
-
Marre M, Bernadet P, Gallois Y, et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994;43:384-388.
-
(1994)
Diabetes
, vol.43
, pp. 384-388
-
-
Marre, M.1
Bernadet, P.2
Gallois, Y.3
-
4
-
-
0029793069
-
A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM
-
Fogarty DG, Harron JC, Hughes AE, et al. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996;45:1204-1208.
-
(1996)
Diabetes
, vol.45
, pp. 1204-1208
-
-
Fogarty, D.G.1
Harron, J.C.2
Hughes, A.E.3
-
5
-
-
0025275128
-
Structure and expression of the human angiotensinogen gene
-
Fukamizu A, Takahashi S, Seo MS, et al. Structure and expression of the human angiotensinogen gene. J Biol Chem 1990;265: 7576-7582.
-
(1990)
J Biol Chem
, vol.265
, pp. 7576-7582
-
-
Fukamizu, A.1
Takahashi, S.2
Seo, M.S.3
-
6
-
-
0026669336
-
Molecular basis of human hypertension: Role of angiotensinogen
-
Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71: 169-180.
-
(1992)
Cell
, vol.71
, pp. 169-180
-
-
Jeunemaitre, X.1
Soubrier, F.2
Kotelevtsev, Y.V.3
-
7
-
-
8044230722
-
Excess of DD homozygotes in haemo-dialysed patients with type II diabetes
-
Schmidt S, Strojek K, Grzeszczak W, et al. Excess of DD homozygotes in haemo-dialysed patients with type II diabetes. Nephrol Dial Transplant 1997;12:427-429.
-
(1997)
Nephrol Dial Transplant
, vol.12
, pp. 427-429
-
-
Schmidt, S.1
Strojek, K.2
Grzeszczak, W.3
-
8
-
-
0030027704
-
Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy
-
Tarnow L, Cambien F, Rossing P, et al. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996;45:367-369.
-
(1996)
Diabetes
, vol.45
, pp. 367-369
-
-
Tarnow, L.1
Cambien, F.2
Rossing, P.3
-
9
-
-
0027441526
-
Angiotensin II causes mesangial cell hypertrophy
-
Anderson PW, Do YS, Hsuch WA. Angiotensin II causes mesangial cell hypertrophy. Hypertension 1993;21:29-35.
-
(1993)
Hypertension
, vol.21
, pp. 29-35
-
-
Anderson, P.W.1
Do, Y.S.2
Hsuch, W.A.3
-
10
-
-
0026409556
-
Differential regulation of angiotensin peptide levels in plasma and kidney of the rat
-
Campbell DJ, Lawrence AC, Towrie A, et al. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991;18:763-773.
-
(1991)
Hypertension
, vol.18
, pp. 763-773
-
-
Campbell, D.J.1
Lawrence, A.C.2
Towrie, A.3
-
11
-
-
0027517659
-
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
-
Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
-
(1993)
N Engl J Med
, vol.329
, pp. 1456-1462
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Bain, R.P.3
-
12
-
-
0028331270
-
Angiotensinogen as a risk factor for essential hypertension in Japan
-
Hata A, Namikawa C, Sasaki M, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93: 1285-1287.
-
(1994)
J Clin Invest
, vol.93
, pp. 1285-1287
-
-
Hata, A.1
Namikawa, C.2
Sasaki, M.3
|